Announcements Trials
Browse Landscape

Phase

Phase NA 28Phase 2 3Phase 3 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Motor Activity 2Prostatic Neoplasms 1Depression 1Cognitive Dysfunction 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × Behavior Therapy × Clear all
NCT04200482 2021-11-04

Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors

Fred Hutchinson Cancer Center

Phase 2 Completed
90 enrolled
Breast

Breast Carcinoma In Situ, Motor Activity

NCT03191968 2019-12-20

BOOST

University of Illinois at Urbana-Champaign

Phase 2 Completed
27 enrolled
Genitourinary

Motor Activity, Prostatic Neoplasms, Cognitive Dysfunction

NCT01748734 2015-06-04

Cognitive Therapy in Reducing Depression in Patients With Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
25 enrolled

Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡